Monodox

In the US, Monodox (doxycycline systemic) is a member of the following drug classes: miscellaneous antimalarials, tetracyclines and is used to treat Acne, Actinomycosis, Amebiasis, Anthrax, Anthrax Prophylaxis, Bacterial Infection, Bartonellosis, Bronchitis, Brucellosis, Bullous Pemphigoid, Chlamydia Infection, Cholera, Cutaneous Bacillus anthracis, Ehrlichiosis, Enterocolitis, Epididymitis - Sexually Transmitted, Gastroenteritis, Granuloma Inguinale, Inclusion Conjunctivitis, Lyme Disease, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Erythema Chronicum Migrans, Lyme Disease - Neurologic, Lymphogranuloma Venereum, Malaria, Malaria Prevention, Melioidosis, Mycoplasma Pneumonia, Nongonococcal Urethritis, Ornithosis, Pelvic Inflammatory Disease, Pemphigoid, Pemphigus, Periodontitis, Plague, Pleural Effusion, Pneumonia, Proctitis, Prostatitis, Psittacosis, Rabbit Fever, Rickettsial Infection, Rosacea, Skin Infection, STD Prophylaxis, Syphilis - Early, Syphilis - Latent, Tertiary Syphilis, Trachoma, Upper Respiratory Tract Infection and Urinary Tract Infection.

US matches:

• Monodox

Ingredient matches for Monodox

Albendazole

Albendazole is reported as an ingredient of Monodox in the following countries:

• Colombia

Doxycycline

Doxycycline is reported as an ingredient of Monodox in the following countries:

• United States

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Monodox in the following countries:

• United States

International Drug Name Search